Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weber, S. M.
Right arrow Articles by Fong, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, S. M.
Right arrow Articles by Fong, Y.
Related Collections
Right arrow Surgery

Annals of Surgical Oncology, Vol 7, Issue 9 643-650, Copyright © 2000 by Society of Surgical Oncology


ARTICLES

Survival after resection of multiple hepatic colorectal metastases

S. M. Weber, W. R. Jarnagin, R. P. DeMatteo, L. H. Blumgart and Y. Fong
Hepatobiliary Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

BACKGROUND: Hepatic resection is potentially curative in selected patients with colorectal metastases. It is a widely held practice that multiple colorectal hepatic metastases are not resected, although outcome after removal of four or more metastases is not well defined. METHODS: Patients with four or more colorectal hepatic metastases who submitted to resection were identified from a prospective database. Number of metastases was determined by serial sectioning of the gross specimen at the time of resection. Demographic data, tumor characteristics, complications, and survival were analyzed. RESULTS: From August 1985 to September 1998, 155 patients with four or more metastatic tumors (range 4-20) underwent potentially curative resection by extended hepatectomy (39%), lobectomy (42%), or multiple segmental resections (19%). Operative morbidity and mortality were 26% and 1%, respectively. Actuarial 5-year survival was 23% for the entire group (median = 32 months) and there were 12 actual 5-year survivors. On multivariate analysis, only number of hepatic tumors (P = .005) and the presence of a positive margin (P = .003) were independent predictors of poor survival. CONCLUSIONS: Hepatic resection in patients with four or more colorectal metastases can achieve long-term survival although the results are less favorable as the number of tumors increases. Number of hepatic metastases alone should not be used as a sole contraindication to resection, but it is clear that the majority of patients will not be cured after resection of multiple lesions.


This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
J. J. Bennett, C. R. Schmidt, D. S. Klimstra, S. R. Grobmyer, N. M. Ishill, M. D'Angelica, R. P. DeMatteo, Y. Fong, L. H. Blumgart, and W. R. Jarnagin
Perihepatic Lymph Node Micrometastases Impact Outcome after Partial Hepatectomy for Colorectal Metastases
Ann. Surg. Oncol., April 1, 2008; 15(4): 1130 - 1136.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
P. V. Korita, T. Wakai, Y. Shirai, J. Sakata, K. Takizawa, P. V. Cruz, Y. Ajioka, and K. Hatakeyama
Intrahepatic Lymphatic Invasion Independently Predicts Poor Survival and Recurrences after Hepatectomy in Patients with Colorectal Carcinoma Liver Metastases
Ann. Surg. Oncol., December 1, 2007; 14(12): 3472 - 3480.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. Liersch, J. Meller, M. Bittrich, B. Kulle, H. Becker, and D. M. Goldenberg
Update of Carcinoembryonic Antigen Radioimmunotherapy with 131I-Labetuzumab After Salvage Resection of Colorectal Liver Metastases: Comparison of Outcome to a Contemporaneous Control Group
Ann. Surg. Oncol., September 1, 2007; 14(9): 2577 - 2590.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
P. Kornprat, W. R. Jarnagin, M. Gonen, R. P. DeMatteo, Y. Fong, L. H. Blumgart, and M. D'Angelica
Outcome After Hepatectomy for Multiple (Four or More) Colorectal Metastases in the Era of Effective Chemotherapy
Ann. Surg. Oncol., March 1, 2007; 14(3): 1151 - 1160.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
H. Korner, K. Soreide, P. J. Stokkeland, and J. A. Soreide
Diagnostic Accuracy of Serum-Carcinoembryonic Antigen in Recurrent Colorectal Cancer: A Receiver Operating Characteristic Curve Analysis
Ann. Surg. Oncol., February 1, 2007; 14(2): 417 - 423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
C. J. Simon, D. E. Dupuy, D. A. Iannitti, D. S. K. Lu, N. C. Yu, B. I. Aswad, R. W. Busuttil, and C. Lassman
Intraoperative Triple Antenna Hepatic Microwave Ablation
Am. J. Roentgenol., October 1, 2006; 187(4): W333 - W340.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. C. G. Martin II, S. A. McGuffin, L. M. Roetzer, T. D. Abell, and J. L. Studts
Method of Presenting Oncology Treatment Outcomes Influences Patient Treatment Decision-Making in Metastatic Colorectal Cancer
Ann. Surg. Oncol., January 1, 2006; 13(1): 86 - 95.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Kuramochi, K. Hayashi, K. Uchida, S. Miyakura, D. Shimizu, D. Vallbohmer, S. Park, K. D. Danenberg, K. Takasaki, and P. V. Danenberg
Vascular Endothelial Growth Factor Messenger RNA Expression Level Is Preserved in Liver Metastases Compared with Corresponding Primary Colorectal Cancer
Clin. Cancer Res., January 1, 2006; 12(1): 29 - 33.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. Chong and D. Cunningham
Improving Long-Term Outcomes for Patients With Liver Metastases From Colorectal Cancer
J. Clin. Oncol., December 20, 2005; 23(36): 9063 - 9066.
[Full Text] [PDF]


Home page
JCOHome page
V. P. Khatri, N. J. Petrelli, and J. Belghiti
Extending the Frontiers of Surgical Therapy for Hepatic Colorectal Metastases: Is There a Limit?
J. Clin. Oncol., November 20, 2005; 23(33): 8490 - 8499.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
C. J. Simon, D. E. Dupuy, and W. W. Mayo-Smith
Microwave Ablation: Principles and Applications
RadioGraphics, October 1, 2005; 25(suppl_1): S69 - S83.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
W. D. Ensminger
A Role for Hepatic-Directed Chemotherapy in Colorectal Liver Metastases
J. Clin. Oncol., August 1, 2005; 23(22): 4815 - 4817.
[Full Text] [PDF]


Home page
Arch SurgHome page
C. D. Mann, M. S. Metcalfe, L. N. Leopardi, and G. J. Maddern
The Clinical Risk Score: Emerging as a Reliable Preoperative Prognostic Index in Hepatectomy for Colorectal Metastases
Arch Surg, November 1, 2004; 139(11): 1168 - 1172.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
Z. Z. R. Hamady, A. Kotru, H. Nishio, and J. P. A. Lodge
Current techniques and results of liver resection for colorectal liver metastases
Br. Med. Bull., October 27, 2004; 70(1): 87 - 104.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
A. S. Wright, F. T. Lee Jr, and D. M. Mahvi
Hepatic Microwave Ablation With Multiple Antennae Results in Synergistically Larger Zones of Coagulation Necrosis
Ann. Surg. Oncol., April 1, 2003; 10(3): 275 - 283.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
J. B. Dimick, J. A. Cowan Jr, J. A. Knol, and G. R. Upchurch Jr
Hepatic Resection in the United States: Indications, Outcomes, and Hospital Procedural Volumes From a Nationally Representative Database
Arch Surg, February 1, 2003; 138(2): 185 - 191.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. P. Hiotis, D. S. Klimstra, K. C. Conlon, and M. F. Brennan
Results After Pancreatic Resection for Metastatic Lesions
Ann. Surg. Oncol., August 1, 2002; 9(7): 675 - 679.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
E. K. Abdalla, C. C. Barnett, D. Doherty, S. A. Curley, and J.-N. Vauthey
Extended Hepatectomy in Patients With Hepatobiliary Malignancies With and Without Preoperative Portal Vein Embolization
Arch Surg, June 1, 2002; 137(6): 675 - 681.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society of Surgical Oncology.